Acido chenodesossicolico Leadiant 250 mg
Acido chenodesossicolico Leadiant 250 mg is a medicine authorised by Swissmedic under authorisation number 66622. The authorisation holder is CD PHARMA (SUISSE) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 June 2018 and the authorisation is valid without a time limit. ATC code A05AA01 places the medicine in the group Bile and liver therapy.
| Authorisation number | 66622 |
|---|---|
| Name | Acido chenodesossicolico Leadiant 250 mg |
| Full name | Acido chenodesossicolico Leadiant 250 mg, capsula rigida |
| Authorisation holder | CD PHARMA (SUISSE) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A05AA01 |
| First authorisation | 28 June 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Acido chenodesossicolico Leadiant 250 mg, capsula rigida | B | 28 June 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 100 | Kapsel(n) | A05AA01 | 04.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Acido chenodesossicolico Leadiant 250 mg authorised in Switzerland?
Yes. Acido chenodesossicolico Leadiant 250 mg is authorised by Swissmedic under authorisation number 66622, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Acido chenodesossicolico Leadiant 250 mg have?
Acido chenodesossicolico Leadiant 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Acido chenodesossicolico Leadiant 250 mg?
The authorisation holder is CD PHARMA (SUISSE) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.